5,696
Participants
Start Date
January 11, 2021
Primary Completion Date
August 31, 2022
Study Completion Date
August 31, 2022
Conditional artemisinin combination therapy subsidy
An additional discount on WHO-approved quality assured ACTs will be offered to individuals with a positive RDT.
Testing incentive
A small incentive will be paid to the provider each time they perform a malaria rapid diagnostic test.
Moi University, Eldoret
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Moi University
OTHER
Clinton Health Access Initiative Inc.
OTHER
Duke University
OTHER